Skip to main content
HR 2194 112th Congress House Health Advisory bodies Digestive and metabolic diseases Health information and medical records Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Sex and reproductive health Women's health

GEDI Act

Introduced: June 15, 2011 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2011
Referred to the Subcommittee on Health.
Jun 15, 2011
Referred to the House Committee on Energy and Commerce.
Jun 15, 2011
Introduced in House
 Plain-English summary Congressional Research Service

Gestational Diabetes Act of 2011 or the GEDI Act - Amends the Public Health Service Act to direct the Director of the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes research project within the diabetes program of the CDC to expand and enhance surveillance data and public health research on gestational diabetes. 

Requires the Secretary of Health and Human Services (HHS) to expand and intensify public health research on gestational diabetes, including; (1) developing and testing novel approaches for improving postpartum testing or screening and for preventing type 2 diabetes in women with a history of gestational diabetes; and (2) conducting research to further understanding of the factors and health systems that influence the risk of gestational diabetes and the development of type 2 diabetes in women with a history of gestational diabetes.

Requires the Director to: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and Indian tribal-based diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.

What's happening now June 22, 2011

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2